Paladin Q1 FY2027 slides: pricing gains offset by production miss
Related news
-
PharmX Q1 FY27 slides: marketplace GTV surges 150%, targets $100m run-rate
-
China’s factory-gate inflation accelerates in September
-
China CPI inflation grows less than expected in Sept; PPI hits 4-yr high
-
Gold holds two-day slide as Fed signals one more hike, U.S. CPI in focus
-
Core Lithium Q3 FY27 slides: first concentrate produced, restart on track
-
Earnings call transcript: PharmX posts 9% revenue growth in Q1 2026 as stock slips
-
Anthropic urges court in Washington, D.C. to rehear appeal of Pentagon blacklisting
-
Ocugen CEO Shankar Musunuri sells $499,691 of company stock